Financial Reporting - BeiGene, Ltd. filed its 2024 Annual Report with the STAR Market of the Shanghai Stock Exchange on April 28, 2025[5]. - The STAR Annual Report includes financial information for the year ended December 31, 2024, prepared in accordance with PRC GAAP[6]. - Financial information prepared under U.S. GAAP is also available, highlighting differences from PRC GAAP[6]. - The financial information includes production, sales, and inventory stock units for the reporting period[6]. Report Content - The report contains details on gross profit margin ratio and R&D expenses allocated by key products[6]. - The filing does not include any new product launches or market expansion strategies[8]. - No specific performance guidance or future outlook was provided in the report[8]. - The report was signed by Chan Lee, Senior Vice President and General Counsel[16]. Accessibility - The STAR Annual Report is publicly available in Chinese on the Shanghai Stock Exchange's website[7]. - The report is not deemed filed with the U.S. Securities and Exchange Commission[7].
BEIGENE(ONC) - 2025 Q1 - Quarterly Results